메뉴 건너뛰기




Volumn 12, Issue 6, 2001, Pages 739-744

Emerging therapies in non-small-cell lung cancer

Author keywords

Docetaxel; Non small cell lung cancer; One year survival; Paclitaxel; Signal transduction inhibitors

Indexed keywords

ANGIOSTATIN; ANTINEOPLASTIC AGENT; BEXAROTENE; CARBOPLATIN; CISPLATIN; DOCETAXEL; ENDOSTATIN; EPIDERMAL GROWTH FACTOR; ETOPOSIDE; FUMAGILLOL CHLOROACETYLCARBAMATE; GAMMA INTERFERON; GEFITINIB; GEMCITABINE; GRANULOCYTE COLONY STIMULATING FACTOR; IFOSFAMIDE; LONAFARNIB; NAVELBINE; PACLITAXEL; PROTEIN TYROSINE KINASE INHIBITOR; RETINOIC ACID; RETINOIC ACID RECEPTOR; TIPIFARNIB; VASCULOTROPIN; VINDESINE;

EID: 0034948211     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1011197500223     Document Type: Review
Times cited : (55)

References (35)
  • 4
    • 0023922084 scopus 로고
    • Chemotherapy can prolong survival in patients with advanced non-small-cell lung cancer-report of a Canadian multicenter randomized trial
    • (1988) J Clin Oncol , vol.6 , pp. 633-641
    • Rapp, E.1    Pater, J.L.2    Willan, A.3
  • 5
    • 0024562637 scopus 로고
    • Supportive care vs. supportive care and combination chemotherapy in metastatic non-small-cell lung cancer. Does chemotherapy make a difference?
    • (1989) Cancer , vol.63 , pp. 1271-1278
    • Ganz, P.A.1    Figlin, R.A.2    Haskell, C.M.3
  • 6
    • 0027159808 scopus 로고
    • Cisplatin-cyclophosphamide-mitomycin combination chemotherapy with supportive care vs. supportive care alone for treatment of metastatic non-small-cell lung cancer
    • (1993) J Natl Cancer Inst , vol.85 , pp. 794-800
    • Cartei, G.1    Cartei, F.2    Cantone, A.3
  • 8
    • 0034160108 scopus 로고    scopus 로고
    • A multicenter, randomized, phase III study of docetaxel plus best supportive care vs. best supportive care in chemotherapy-naïve patients with metastatic or non-resectable localized non-small-cell lung cancer (NSCLC)
    • (2000) Lung Cancer , vol.37 , Issue.3 , pp. 145-157
    • Roszkowski, K.1    Pluzanska, A.2    Krzakowski, M.3
  • 10
    • 0006453669 scopus 로고    scopus 로고
    • Effects of vinorelbine on quality of life and survival of elderly patients with advanced non-small-cell lung cancer
    • The Elderly Lung Cancer Vinorelbine Italian Study Group
    • (1999) J Natl Cancer Inst , vol.91 , pp. 66-72
  • 11
    • 0001913280 scopus 로고    scopus 로고
    • Phase III study of gemcitabine (Gemzar®) vs. best supportive care (BSC) in advanced non-small-cell lung cancer (NSCLC)
    • (Abstr 24 and oral presentation in Dublin, Ireland, 1997).
    • (1997) Lung Cancer , vol.18 , Issue.1 , pp. 9
    • Anderson, H.1    Cottier, B.2    Nicolson, M.3
  • 12
    • 0033950286 scopus 로고    scopus 로고
    • Comparison of survival and quality of life in advanced non-small-cell lung cancer patients treated with two dose levels of paclitaxel combined with cisplatin vs. etoposide with cisplatin: Results of an Eastern Cooperative Group trial
    • (2000) J Clin Oncol , vol.18 , pp. 623-631
    • Bonomi, P.1    Kim, K.M.2    Fairclough, D.3
  • 13
    • 0028154069 scopus 로고
    • Randomized study of vinorelbine and cisplatin vs. vindesine and cisplatin vs. vinorelbine alone in advanced non-small-cell lung cancer: Results of a European multicenter trial including 612 patients
    • (1994) J Clin Oncol , vol.12 , pp. 360-367
    • Le Chevalier, T.1    Brisgand, D.2    Douillard, J.Y.3
  • 15
    • 0000510626 scopus 로고    scopus 로고
    • A randomized phase III trial of paclitaxel plus carboplatin (PC) vs. vinorelbine plus cisplatin (VC) in untreated advanced non-small-cell lung cancer (NSCLC): A Southwest Oncology Group (SWOG) trial
    • (Abstr 1777)
    • (1999) Proc Am Soc Clin Oncol , vol.18 a
    • Kelly, K.1    Crowley, J.2    Bunn, P.3
  • 17
    • 0030878725 scopus 로고    scopus 로고
    • Single-agent docetaxel in previously untreated non-small-cell lung cancer
    • (1997) Oncology , vol.11 , Issue.SUPPL. 7 , pp. 17-21
    • Rigas, J.R.1
  • 24
    • 0034069620 scopus 로고    scopus 로고
    • Prospective randomized trial of docetaxel vs. best supportive care in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy
    • (2000) J Clin Oncol , vol.18 , Issue.10 , pp. 2095-2103
    • Shepherd, F.1    Ramlau, R.2    Mattson, K.3
  • 25
    • 0034095853 scopus 로고    scopus 로고
    • Randomized phase III trial of docetaxel vs. vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum-based chemotherapy
    • (2000) J Clin Oncol , vol.18 , Issue.12 , pp. 2354-2362
    • Fossella, F.V.1    DeVore, R.2    Kerr, R.3
  • 31
    • 0028937815 scopus 로고
    • Epidermal growth factor (EGFR) expression in non small-cell lung carcinomas correlates with metastic involvement of the hilar and mediastinal lymph nodes squamous subtypes
    • (1995) Eur J Cancer , vol.31 A , pp. 178-183
    • Fontanini, G.1    Vignati, S.2    Bigini, D.3
  • 33
    • 0000240853 scopus 로고    scopus 로고
    • Continuous administration of ZD1839 (Iressa), a novel oral epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI), in patients with five selected tumor types: Evidence of activity and good tolerability
    • (Abstr 686)
    • (2000) Proc Am Soc Clin Oncol , vol.19
    • Baselga, J.1    Herbst, R.2    Lorusso, P.3
  • 34
    • 0000397265 scopus 로고    scopus 로고
    • A randomized phase II trial comparing rhuMab VEGF (recombinant humanized monoclonal antibody to vascular endothelial cell growth factor) plus carboplatin/paclitaxel alone in patients with stage IIIB/IV NSCLC
    • (Abstr 1896)
    • (2000) Proc Am Soc Clin Oncol , vol.19 , pp. 485
    • DeVore, R.F.1    Fehrenbacher, L.2    Herbst, R.S.3
  • 35
    • 0028843552 scopus 로고
    • Non-Small-Cell Lung Cancer Collaborative Group: Chemotherapy in non-small-cell lung cancer: A meta-analysis using updated data on individual patients from 52 randomized clinical trials
    • (1995) BMJ , vol.311 , pp. 899-909


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.